Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

      NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

      Meghna A Singhania3 March 2019 10:45 AM IST
      New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) revises the ceiling...
      NPPA fixes retail price of Sun Pharma Baclofen Oral Solution

      NPPA fixes retail price of Sun Pharma Baclofen Oral Solution

      Meghna A Singhania3 March 2019 10:15 AM IST
      New Delhi: Through a recent notification, the drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of...
      We have Faith In Indian Judiciary: IHH CEO on Fortis Deal

      We have Faith In Indian Judiciary: IHH CEO on Fortis Deal

      Meghna A Singhania2 March 2019 2:59 PM IST
      New Delhi: As the fate of Fortis-IHH deal hangs in balance, all eyes are now at the next hearing in the Supreme Court on status quo is scheduled on...
      NPPA fixes retail price of 21 drugs including BP, diabetes, painkillers; Details

      NPPA fixes retail price of 21 drugs including BP, diabetes, painkillers; Details

      Meghna A Singhania1 March 2019 6:13 PM IST
      The NPPA order is likely to affect drug majors including Lupin, Emcure, Cipla, Mylan, Zydus, Macleods Pharmaceuticals.New Delhi: Through a recent...
      NPPA caps trade margins to 30 percent for 42 cancer drugs

      NPPA caps trade margins to 30 percent for 42 cancer drugs

      Meghna A Singhania28 Feb 2019 9:20 AM IST
      As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it...
      First Time: India releases guidelines on Nanopharmaceuticals; DBT asks for feedback

      First Time: India releases guidelines on Nanopharmaceuticals; DBT asks for feedback

      Meghna A Singhania27 Feb 2019 1:19 PM IST
      Nanopharmaceuticals can be targeted to the site of the disease using the nanocarriers, it improves the safety and potency of certain drugs by lowering...
      Digital health services are transforming health sector in India: Nadda

      Digital health services are transforming health sector in India: Nadda

      Meghna A Singhania27 Feb 2019 9:00 AM IST
      The Global Digital Health Partnership facilitates global collaboration and co-operation in the implementation of digital health services.New Delhi:...
      Launching product without Approval: DOP rejects Biocon Plea against NPPA action

      Launching product without Approval: DOP rejects Biocon Plea against NPPA action

      Meghna A Singhania24 Feb 2019 11:25 AM IST
      New Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
      Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

      Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

      Meghna A Singhania23 Feb 2019 12:57 PM IST
      The high court has now ruled in favour of Lupin and quashed the apex court's decision to ban Lupin's anti-diabetic drug- Gluconorm P 30.New Delhi: In...
      Supreme Court lifts ban on Saridon, major relief to Piramal

      Supreme Court lifts ban on Saridon, major relief to Piramal

      Meghna A Singhania21 Feb 2019 6:05 PM IST
      New Delhi: In a major relief to Piramal, the Supreme Court has exempted the popular painkiller drug Saridon from the list of Fixed Dose Combinations...
      NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

      NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

      Meghna A Singhania21 Feb 2019 3:13 PM IST
      However, the move is likely to stimulate retailers to spend more as trade margins on drugs that have somehow bypassed the list and the retailers may...
      Taking steps to ensure availability of affordable medicines to common people: Gowda

      Taking steps to ensure availability of affordable medicines to common people: Gowda

      Meghna A Singhania19 Feb 2019 9:15 AM IST
      "The government has ensured that generic medicines are available across the country in over 5,000 Jan Aushadhi Kendra," he told here on the sidelines...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok